J
Jeanna M. Marraffa
Researcher at State University of New York Upstate Medical University
Publications - 44
Citations - 1372
Jeanna M. Marraffa is an academic researcher from State University of New York Upstate Medical University. The author has contributed to research in topics: Poison control & Medicine. The author has an hindex of 18, co-authored 39 publications receiving 1122 citations. Previous affiliations of Jeanna M. Marraffa include State University of New York System & Syracuse University.
Papers
More filters
Journal ArticleDOI
Cleaning and Disinfectant Chemical Exposures and Temporal Associations with COVID-19 - National Poison Data System, United States, January 1, 2020-March 31, 2020.
Arthur Chang,Amy H. Schnall,Royal Law,Alvin C. Bronstein,Jeanna M. Marraffa,Henry A. Spiller,Hannah L. Hays,Alexandra R. Funk,Maria Mercurio-Zappala,Diane P. Calello,Alfred Aleguas,Douglas J. Borys,Tegan K. Boehmer,Erik R. Svendsen +13 more
TL;DR: Although NPDS data do not provide information showing a definite link between exposures and COVID-19 cleaning efforts, there appears to be a clear temporal association with increased use of these products.
Journal Article
Acute Kidney Injury Associated with Synthetic Cannabinoid Use — Multiple States, 2012
Tracy D. Murphy,Kelly N. Weidenbach,Clay Van Houten,Roy Gerona,Jeffery H. Moran,Ronald I. Kirschner,Jeanna M. Marraffa,Christine M. Stork,Guthrie S. Birkhead,Andie Newman,Robert G. Hendrickson,B. Zane Horowitz,Karen Vian,Richard Leman,Stephen L. Thornton,Clayton Wood,David A. Myers,Erik Orr,John J. Devlin,Michael D. Schwartz,Genevieve L. Buser +20 more
TL;DR: The results of the investigation determined that no single SC brand or compound explained all 16 cases, and public health practitioners, poison center staff members, and clinicians should be aware of the potential for renal or other unusual toxicities in users of SC products and should ask about SC use in cases of unexplained AKI.
Journal ArticleDOI
E-cigarette, or vaping, product use associated lung injury (EVALI): case series and diagnostic approach
A. Kalininskiy,Christina T Bach,Christina T Bach,Nicholas E Nacca,Nicholas E Nacca,Nicholas E Nacca,Gary Ginsberg,Jeanna M. Marraffa,Jeanna M. Marraffa,Kristen A. Navarette,Kristen A. Navarette,Matthew D. McGraw,Matthew D. McGraw,Daniel P. Croft,Daniel P. Croft +14 more
TL;DR: A novel clinical practice algorithm based on statewide physician feedback and input from experts in environmental health, medical toxicology, infectious disease, epidemiology, and chronic disease prevention is presented which will be useful for both acute management and improved accurate reporting of this life-threatening respiratory illness.
Journal ArticleDOI
The synthetic cannabinoid withdrawal syndrome.
TL;DR: The acute withdrawal syndrome appears to be characterized mainly by anxiety and tachycardia in the absence of any neurological findings or electrolyte disturbances.
Journal ArticleDOI
Cardiac conduction disturbance after loperamide abuse
Jeanna M. Marraffa,Michael G. Holland,Ross W. Sullivan,Brent W. Morgan,J. A. Oakes,Timothy J. Wiegand,Michael Hodgman +6 more
TL;DR: This case series describes several patients with cardiac conduction abnormalities and life-threatening ventricular arrhythmias temporally related to loperamide abuse, with the recent efforts to restrict the diversion of prescription opioids, increasing abuse of lopersamide as an opioid substitute may be seen.